---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-23-031574"
form_type: "8-K"
ticker: "AMS"
cik: "0000744825"
company_name: "AMERICAN SHARED HOSPITAL SERVICES"
filed_at: "2023-11-13T23:59:59+00:00"
generated_at: "2026-06-08T05:53:46.385329+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# American Shared Hospital Services Q3 revenue up 6.3% to $5.1M; net income falls to $0.02/sh

## Summary
- Revenue $5.134M (+6.3% YoY); gross margin 40.9% vs 40.5%.
- Net income $118k ($0.02 diluted) vs $316k ($0.05) in Q3 2022; operating income $90k vs $448k.
- Adjusted EBITDA $1.669M vs $1.966M; selling/admin costs up 37.7% to $1.735M on new business investment.
- Cash $14.655M at Sept 30, up from $12.453M at Dec 31; equity $3.53/sh.
- Two new Gamma Knife Esprit upgrade orders from existing customers; international centers advancing (Ecuador restart, Mexico LINAC Q1 2024).

## SEC filing metadata
- accession: 0001437749-23-031574
- form_type: 8-K
- ticker: AMS
- cik: 0000744825
- company_name: AMERICAN SHARED HOSPITAL SERVICES
- filed_at: 2023-11-13T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/744825/000143774923031574/0001437749-23-031574-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/744825/000143774923031574/asha20231107_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-23-031574
- JSON: https://secwatch.observer/filing/0001437749-23-031574.json
- Plain text: https://secwatch.observer/filing/0001437749-23-031574.txt

## Key facts
- Earnings Releases
  AMERICAN SHARED HOSPITAL SERVICES reported the third quarter ended September 30, 2023 results: revenue $5,134,000, net income $118,000, EPS $0.02 per diluted share.
  - Period: the third quarter ended September 30, 2023
  - Revenue: $5,134,000
  - Net income: $118,000
  - EPS: $0.02 per diluted share
  - Result: reported results
  source text: systems and services, today announced financial results for the third quarter ended September 30, 2023. Third Quarter 2023 Highlights ● Total revenue in the third quarter was $5,134,000, an increase of 6.3% from the comparable period in 2022. Total proton therapy revenue decreased 5.9% period-over-period; fractions decreased 12.8%. Gamma Knife revenue increased
  evidence_url: https://www.sec.gov/Archives/edgar/data/744825/000143774923031574/0001437749-23-031574-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.